文献速递多重用药老年慢病共病管理

老年患者使用呋喃妥因的肺与肝不良反应发生率

How Common Are Pulmonary and Hepatic Adverse Effects in Older Adults Prescribed Nitrofurantoin?
PubMed 文献 · J Am Geriatr Soc · 2017-03-17

该回顾性电子病历审计纳入2010至2014年某城市学术医疗中心3400例65岁及以上呋喃妥因处方者,641例初筛可能相关症状者经详细病历审查后,3.9%疑为呋喃妥因所致不良反应,仅5例高度怀疑毒性(4例肺毒性、1例肝毒性),其中4例为长期使用。

要点

  • 老年呋喃妥因处方者中严重肺肝不良反应不常见,但长期使用风险更高。
  • 初筛641例中仅3.9%疑为药物不良反应,高度怀疑毒性者仅5例。
  • 5例高度怀疑毒性者中4例为长期使用呋喃妥因。

核心结论

  • 65岁及以上人群使用呋喃妥因时严重肺肝不良反应似乎不常见,但长期使用风险更高。

主要发现

  • 3400例65岁及以上呋喃妥因处方者中,641例初筛可能具有五种目标肺肝症状或疾病并发症之一。
  • 详细病历审查后,89%无不良反应,7%有轻微副作用或过敏,3.9%符合疑为呋喃妥因所致不良反应标准。
  • 3.9%疑为药物不良反应者中,5例高度怀疑呋喃妥因毒性,其中4例肺毒性、1例肝毒性。
  • 5例高度怀疑毒性者中4例长期使用呋喃妥因。

临床怎么用

  • 对65岁及以上患者处方呋喃妥因时,应关注肺肝不良反应,尤其长期用药者需警惕毒性风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To determine the frequency of serious pulmonary and hepatic adverse events (AEs) in persons aged 65 and older prescribed nitrofurantoin. DESIGN: Retrospective electronic health record (EHR) audit of nitrofurantoin prescriptions and associated AEs. SETTING: Urban academic medical center. PARTICIPANTS: All inpatients and outpatients aged 65 and older prescribed nitrofurantoin from January 1, 2010, to December 31, 2014. MEASUREMENTS: The number of nitrofurantoin prescriptions and pulmonary and hepatic AEs associated with nitrofurantoin use was acquired by data extraction from EHRs. RESULTS: Of 3,400 individuals aged 65 and older prescribed nitrofurantoin during the study period, 641 were identified as possibly having one of five targeted symptoms or disease complications (pulmonary and hepatic) associated with nitrofurantoin. After a detailed chart audit, 89% were deemed to have no adverse reaction, 7% had a minor side effect or allergy, and 3.9% met criteria for suspicion of a nitrofurantoin-induced AE, five of whom were rated as being highly suspicious for nitrofurantoin toxicity; four of the five were identified with pulmonary toxicity and one with hepatotoxicity. Four of five of these individuals used nitrofurantoin chronically. CONCLUSION: Nitrofurantoin was prescribed for 3,400 individuals aged 65 and older during the 5-year study period. Serious side effects appeared to be uncommon, but chronic use appeared to be at greater risk.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Claussen K, Stocks E, Bhat D, et al. How Common Are Pulmonary and Hepatic Adverse Effects in Older Adults Prescribed Nitrofurantoin? J Am Geriatr Soc. 2017. PMID: 28306135. doi:10.1111/jgs.14796

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。